Amir Nashat Insider Trading $RCPT Receptos, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Amir Nashat.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Amir Nashat. Amir Nashat is Director in aTYR PHARMA INC ($LIFE) and Director in BIND Therapeutics, Inc ($BIND) and Director in FATE THERAPEUTICS INC ($FATE) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Receptos, Inc. ($RCPT) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Metacrine, Inc. ($MTCR) and Director in Morphic Holding, Inc. ($MORF) and Director in Scholar Rock Holding Corp ($SRRK).

Amir Nashat in Receptos, Inc.

Trading Symbol: RCPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 1,186,940 shares
Latest Transaction: Jul 19 2013

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Amir Nashat in Receptos, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, LIFE, BIND, FATE, MTCR, MORF, RCPT, SRRK, SELB, SYRS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 19 2013	RCPT	Receptos, Inc.	Nashat Amir	Director	Option Exercise	A	18.77	18,800	352,876	18,800
May 14 2013	RCPT	Receptos, Inc.	Nashat Amir	Director	Option Exercise	C	7.73	7,766,989	60,038,825	0
May 14 2013	RCPT	Receptos, Inc.	Nashat Amir	Director	Buy	P	14.00	151,343	2,118,802	1,186,940	1 M to 1.2 M (+14.61 %)
May 14 2013	RCPT	Receptos, Inc.	Nashat Amir	Director	Buy	C	7.73	1,035,597	8,005,165	1,035,597	0 to 1 M

Page: 1